The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nash Duane since 2015.
This trader's CIK number is 1591098.
At the time of last reporting, Nash Duane was the Executive Chairman of Immunic, Inc.. (stock ticker symbol IMUX).
Also see all insider trading activities at Immunic, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | AKBA | 0 | $0 | 1,000 | $14,620 | 0 | $0 |
2017 | AKBA | 0 | $0 | 5,149 | $67,288 | 0 | $0 |
2016 | AKBA | 0 | $0 | 3,961 | $32,563 | 0 | $0 |
2015 | AKBA | 0 | $0 | 3,983 | $38,560 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | IMUX | 20,000 | $16,700 | 0 | $0 | 0 | $0 |
2022 | IMUX | 10,000 | $50,300 | 0 | $0 | 0 | $0 |
2021 | IMUX | 5,000 | $60,800 | 0 | $0 | 0 | $0 |
2019 | IMUX | 0 | $0 | 4,400 | $30,624 | 22,157 | $0 |
2017 | IMUX | 3,900 | $12,183 | 0 | $0 | 0 | $0 |
1. Akebia Therapeutics, Inc. (AKBA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-02-15 | AKBA | Sale | 1,000 | 14.62 | 14,620 |
2017-10-02 | AKBA | Sale | 1,188 | 19.64 | 23,332 |
2017-07-03 | AKBA | Sale | 990 | 14.27 | 14,127 |
2017-04-03 | AKBA | Sale | 991 | 9.20 | 9,119 |
2017-01-03 | AKBA | Sale | 1,980 | 10.46 | 20,710 |
2016-10-03 | AKBA | Sale | 1,981 | 8.96 | 17,745 |
2016-07-06 | AKBA | Sale | 1,980 | 7.48 | 14,818 |
2015-10-02 | AKBA | Sale | 996 | 8.65 | 8,617 |
2015-07-02 | AKBA | Sale | 996 | 9.53 | 9,489 |
2015-04-02 | AKBA | Sale | 996 | 9.09 | 9,051 |
2015-01-02 | AKBA | Sale | 995 | 11.46 | 11,403 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-13 | IMUX | Buy | 20,000 | .83 | 16,700 |
2022-05-12 | IMUX | Buy | 10,000 | 5.03 | 50,300 |
2021-08-10 | IMUX | Buy | 1,000 | 9.80 | 9,800 |
2021-05-12 | IMUX | Buy | 4,000 | 12.75 | 51,000 |
2019-12-02 | IMUX | Option Ex | 22,157 | .00 | 0 |
2019-12-04 | IMUX | Sale | 4,400 | 6.96 | 30,624 |
2017-06-08 | VTL | Buy | 3,900 | 3.12 | 12,183 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nash Duane (Executive Chairman of Immunic, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.